News

SAN DIEGO–(BUSINESS WIRE)–Boundless Bio, a next-generation precision oncology company developing innovative therapeutics directed against extrachromosomal DNA (ecDNA) in aggressive cancers, today announced plans to present at the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics, held virtually from October 7-10, 2021. Boundless Bio, in collaboration with the Dana… Click here to view original post… […]

SAN DIEGO–(BUSINESS WIRE)–Vividion Therapeutics Announces Formation of Scientific Advisory Board Click here to view original post… […]

SAN DIEGO & LONDON–(BUSINESS WIRE)– #LawSocAwards–Scientist.com General Counsel, Sarah Harkcom, shortlisted by The Law Society Awards for the In-house Solicitor of the Year category. Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Sept. 21, 2021 /PRNewswire/ — HUYABIO International (HUYABIO™), the leader in accelerating global development of China’s pharmaceutical innovations, announced today the first patient treated in a pivotal trial designed to measure the safety and efficacy of HBI-8000 combined with Bristol Myers Squibb’s anti-PD-1, antibody Opdivo® (nivolumab),… Click here to view original post… […]

European antitrust regulator delivers ultimatum to Illumina over $8B Grail deal
chale
Tue, 09/21/2021 – 16:04
Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Sept. 21, 2021 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that Barry Quart, Pharm.D., Chairman and Chief Executive Officer,… Click here to view original post… […]

A week before the FDA is set to decide on Mirum Pharmaceuticals’ lead liver disease drug — an old Shire cast-off called maralixibat — Takeda is swooping in to secure the rights in Japan. Maralixibat’s roots trace back to Lumena, which was snapped up by… Click here to view original post… […]

SOUTH SAN FRANCISCO, Calif.: SOUTH SAN FRANCISCO, Calif., Sept. 21, 2021 /PRNewswire/ — Explora BioLabs, a national provider of industry-leading preclinical vivarium research space and management services based in San Diego, opened a new facility here on Sept. 20, 2021. The new vivarium, located in South San Francisco, East Side,… Click here to view original post… […]

SAN DIEGO–(BUSINESS WIRE)–Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation and oncology, today announced that, Bryan Giraudo has been appointed Chief Operating Officer, in addition to his continued role as Chief Financial Officer. Mr…. Click here to view original post… […]

When Genentech swooped in to buy NASH-focused Jecure Therapeutics back in 2018, a handful of the startup’s executives weren’t quite ready to disperse. It had been just three years since Jecure launched with a preclinical portfolio of NLRP3 inhibitors — and the takeover came sooner than anyone, including CEO… Click here to view original post… […]

SAN DIEGO and PERTH, Australia: SAN DIEGO and PERTH, Australia, Sept. 21, 2021 /PRNewswire/ — PYC Therapeutics (ASX: PYC), a biotechnology company combining two complementary platform technologies (selective drug delivery and precision drug design) to develop a new generation of RNA therapeutics to change the lives of patients with inherited… Click here to view original post… […]

SAN DIEGO–(BUSINESS WIRE)–Blackstone’s BioMed Realty announces plans to double the size of its UK life sciences portfolio Click here to view original post… […]

The San Diego biotech is developing drugs that precisely target tumors already impervious to other therapies Click here to view original post… […]

Illumina Ventures sets sights on European genomics startups with new $325M fund
chale
Mon, 09/20/2021 – 10:58
Click here to view original post… […]

Illumina Ventures closed off its second investment fund with a total commitment of $325 million, offering fresh fuel to back a slate of startups that have already included a smorgasbord of companies, covering everything from diagnostics to biotech drug development and genomics. … […]

SAN DIEGO: SAN DIEGO, Sept. 20, 2021 /PRNewswire/ — Neurelis, Inc. announced today that it has initiated a clinical program to investigate the use of VALTOCO® (diazepam nasal spray) in children with epilepsy aged two to five as a treatment for seizure clusters. VALTOCO is currently approved by the U.S…. Click here to view original post… […]

SAN DIEGO–(BUSINESS WIRE)–XIFIN introduced the newest iteration of its cloud-based laboratory information system (LIS), XIFIN LIS 8. Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Sept. 20, 2021 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced results from a post hoc exploratory analysis of the Phase 2 study, MRTX-500. Results showed durable responses and long-term survival with sitravatinib in combination with nivolumab (OPDIVO®)1 in patients… Click here to view original post… […]

CARLSBAD, Calif.: CARLSBAD, Calif., Sept. 20, 2021 /PRNewswire/ — Addressing the need to make adeno-associated virus (AAV) production more efficient and scalable, Thermo Fisher Scientific has launched the integrated Gibco AAV-MAX Helper Free AAV Production System*, a complete, optimized solution that simplifies the AAV vector production workflow. The all-in-one AAV-MAX… Click here to view original post… […]

SAN DIEGO and CALGARY, AB: SAN DIEGO and CALGARY, AB, Sept. 20, 2021 /PRNewswire/ — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced preclinical data demonstrating the synergistic immunotherapeutic effects of pelareorep combined with radiotherapy in a murine cancer model. The data were featured in a poster presentation at… Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Sept. 20, 2021 /PRNewswire/ — Aristea Therapeutics (Aristea), a clinical-stage immunology focused drug development company developing novel therapies to treat rare serious inflammatory diseases, today announced that James Mackay, Ph.D., President and CEO, will participate in the following investor conferences in September and October: UBS Private… Click here to view original post… […]

SAN FRANCISCO–(BUSINESS WIRE)–Illumina Ventures, an independently-managed, healthcare-focused venture firm, announced today the closing of its second investment fund with total commitments of $325 million, bringing its total capital under management to $560 million. The latest fund is anchored by Illumina, Inc. (Nasdaq: ILMN), with the majority of the total committed… Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Sept. 20, 2021 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced the appointment of David Meek as Chief Executive Officer (CEO), effective immediately. Mr. Meek will also join the Company’s Board of Directors. Charles M. Baum, M.D., Ph.D. will continue… Click here to view original post… […]

SAN DIEGO: SAN DIEGO, Sept. 18, 2021 /PRNewswire/ — Epic Sciences, Inc.’s (Epic) Comprehensive Cancer Profiling™ Platform continues to deliver compelling cell analysis information in clinical trials as data being presented today at the virtual European Society for Medical Oncology Congress 2021 (ESMO 2021) demonstrate. Data from abstract 577O –… Click here to view original post… […]